Company Filing History:
Years Active: 2014
Title: Ariane Fischer: Innovator in Cardiac Health
Introduction
Ariane Fischer is a notable inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of cardiac health through her innovative research and patents. Her work focuses on the treatment and prevention of age-related cardiomyopathy, a condition that affects the heart's ability to function properly as individuals age.
Latest Patents
Ariane Fischer holds a patent for "Micro-RNA for the regulation of cardiac apoptosis and contractile function." This invention relates to treating or preventing age-related cardiomyopathy by modulating the expression or activity of a miR-34 family member and/or PNUTS. The methods outlined in her patent include administering an inhibitor of miR-34 expression or activity or an agonist of PNUTS expression or activity. Additionally, her patent provides methods for treating or preventing cardiac fibrosis and myocardial infarction using similar approaches.
Career Highlights
Ariane Fischer is currently associated with Migagen Therapeutics, Inc., where she continues her research and development efforts in cardiac health. Her work has the potential to significantly impact the treatment of heart-related conditions, improving the quality of life for many individuals.
Collaborations
Ariane has collaborated with esteemed colleagues in her field, including Stefanie Dimmeler and Reinier Boon. These collaborations have further enhanced her research and contributed to the advancement of cardiac health innovations.
Conclusion
Ariane Fischer is a pioneering inventor whose work in cardiac health is making strides in the treatment of age-related conditions. Her innovative approaches and patented methods hold promise for improving heart health and patient outcomes.